Table 2.
Attributes and personal characteristics | Main effects model | Model including characteristics | ||
---|---|---|---|---|
Mean | SD | Mean | SD | |
Chance of having a genetic condition (%) | 0.01599a | 0.02508a | 0.01570a | 0.02549a |
Severity of the condition (moderate) | 0.37130a | 0.04901 | 0.35943a | 0.03815 |
Severity of the condition (severe) | 0.80142a | 0.59507a | 0.80357a | 0.65083a |
Availability of preventive or treatment options (improve condition) | 1.00341a | 0.10757 | 1.00345a | 0.25353 |
Availability of preventive or treatment options (cure/prevent condition) | 1.34510a | 0.99157a | 1.33651a | 0.98354a |
Improving the process of medical care (somewhat likely) | 0.50200a | 0.02369 | 0.48779a | 0.07495 |
Improving the process of medical care (very likely) | 0.65578a | 0.63296a | 0.66276a | 0.57324a |
Disclosure of test results to others | −0.14570b | 0.05948b | −0.13879b | 0.05667b |
Disclosure of secondary findings to you | 0.29280a | 0.77554a | 0.26783a | 0.73807a |
Cost of testing to you | −0.00028a | 0.00011a | −0.00028a | 0.00011a |
Genomic sequencing constant | −0.97032a | 3.39515a | −11.1476a | 0.18166 |
Age | −0.02792c | |||
Higher education | 0.79242c | |||
Attitudes toward genomics | 0.29037a | |||
Log likelihood function | −3832.70 | −3817.53 | ||
McFadden pseudo R-squared | 0.35 | 0.35 | ||
Akaike information criterion | 7707.00 | 7699.10 |
aStatistical significance at 1%.
bStatistical significance at 5%.
cStatistical significance at 10%.
Regression coefficients indicate the marginal effect of each attribute (or attribute level) on the utility for genomic sequencing. Positive (or negative) mean estimates indicate, on average, a positive (or negative) effect on utility. Standard deviation estimates describe the heterogeneity of preferences among study participants.